# Clinical Trial Enzyme Application Targeting Venous Leg Ulcers

> **NCT04956900** · PHASE2 · COMPLETED · sponsor: **SolasCure Limited** · enrollment: 43 (actual)

## Conditions studied

- Venous Leg Ulcer
- Leg Injuries and Disorders

## Interventions

- **DRUG:** Aurase Wound gel

## Key facts

- **NCT ID:** NCT04956900
- **Lead sponsor:** SolasCure Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-09
- **Primary completion:** 2023-02-06
- **Final completion:** 2023-02-06
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2023-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04956900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04956900, "Clinical Trial Enzyme Application Targeting Venous Leg Ulcers". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT04956900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*